March 5, 2019 Dear Friends and Supporters of the CLL Society, New this week! At ASH 2018, Professor Hallek shared his thoughts on the direction... March 5, 2019NewslettersBy Brad Hedrick
February 26, 2019 Dear Friends and Supporters of the CLL Society, New this week! Dr. Nicole Lamanna describes the potential benefits available to patients who... February 26, 2019NewslettersBy Brad Hedrick
February 19, 2019 Dear Friends and Supporters of the CLL Society, New this week! The CLL Society is pleased to have new writers present our... February 19, 2019NewslettersBy Brad Hedrick
February 12, 2019 Dear Friends and Supporters of the CLL Society, At ASH 2018, Dr. Byrd shares the promising results of acalabrutinib in a... February 12, 2019NewslettersBy Brad Hedrick
February 5, 2019 Dear Friends and Supporters of the CLL Society, The ability to block the B cell receptor (BCR) with drugs has radically... February 5, 2019NewslettersBy Brad Hedrick
January 29, 2019 Dear Friends and Supporters of the CLL Society, I interviewed Dr. Rick Furman to set the stage for how to best... January 29, 2019NewslettersBy Brad Hedrick
January 22, 2019 Dear Friends and Supporters of the CLL Society, Thanks to all of you who have completed our brief survey for the... January 22, 2019NewslettersBy Brad Hedrick
January 15, 2019 Dear Friends and Supporters of the CLL Society, Register now for our post-ASH CLL Society Educational Forums in February: Join us live... January 15, 2019NewslettersBy Brad Hedrick
January 8, 2019 Dear Friends and Supporters of the CLL Society, This week we continue our reporting from ASH 2018 by sharing our interview... January 8, 2019NewslettersBy Brad Hedrick
December 31, 2018 Dear Friends and Supporters of the CLL Society, It has been a year of polar contrasts, with the sadness of the... December 31, 2018NewslettersBy Brad Hedrick
